Beza Tasew Degefu

Dr. Beza Tasew Degefu

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
GDGetahun Tsegaye Dibaba
Getahun Tsegaye Dibaba
ALAbebaye Aragaw Leminie
Abebaye Aragaw Leminie
WTWossene Habtu Tadesse
Wossene Habtu Tadesse
WLWorku Gemechu Lemmi
Worku Gemechu Lemmi
SHSamuel Woldekidan Hirpesa
Samuel Woldekidan Hirpesa
MCMenberework Chanyalew
Menberework Chanyalew
Background: Diabetic animals show increased plasma glucose, cholesterol, triglycerides, and low-density lipoprotein levels, along with decreased body weight and glycogen in the liver and muscles. While effective diabetic treatments are still being investigated, plants and herbs have historically contributed to treatment of ailments. The current study explores an alternative, complementary and potential treatment for diabetes. In ethno-medicine, various parts of Mangifera indica are used to treat diabetes mellitus. Methods: The present study aims at investigating antidiabetic, hypolipidemic, and histopathological analysis of Mangifera indica leaf methanolic extract (MIME) in streptozotocin-induced diabetic mice by administering different oral doses (200,400 and 600 mg/kg body weight). After induction of diabetes, the animals are assigned into six groups (one control group and five treatment groups). The treatment groups are treated by different dose of extract, and glibenclamide, and their blood glucose levels were measured. The BGL recording is done using blood glucose test strips OneTouch glucometer on weekly intervals for five weeks. Hematology and other parameters such as liver, renal and total lipid profiles were determined in normal and streptozotocin-induced diabetic mice after oral administration of the extract for 28 days. Post-treatment histopathological changes in the diabetic mice organs, like the pancreas, liver, and kidney, were assessed at the end of treatments. Results: Daily oral administration of MIME (200,400 and 600 mg/kg body weight) and glibenclamide (6 mg/kg) showed significant effects on blood glucose level (P<0.001) as well as in improving kidney, liver functions and hyperlipidemia due to diabetes. The extract treatment also showed to enhanced body weight of diabetic mice as compared to diabetic control group. The NIME showed a restorative effect on pancrease, liver and kidney from the study of histopathological changes. Conclusions: Mageferin indica possess anti-diabetic property in diabetic mice. It improves body weight, liver profile, renal profile and lipid profiles. It has a favorable effect in inhibiting diabetic-induced damage of islets of Langerhans in the pancreas.

3 February 2026 in Pan African Medical Journal
Verified
Journal Article
Open access
GDGetahun Tsegaye Dibaba
Getahun Tsegaye Dibaba
ALAbebaye Aragaw Leminie
Abebaye Aragaw Leminie
WTWossene Habtu Tadesse
Wossene Habtu Tadesse
WLWorku Gemechu Lemmi
Worku Gemechu Lemmi
SHSamuel Woldekidan Hirpesa
Samuel Woldekidan Hirpesa
TDTesfaye Tolessa Dugul
Tesfaye Tolessa Dugul
Introduction: Psidium guajava (guava) is an important medicinal plant used for gastrointestinal disorders, diabetes, and inflammation, primarily due to its bioactive compounds including flavonoids and tannins. To ensure safety for human use, rigorous preclinical toxicity assessments are essential. The purpose of this study was to assess the safety of ethanol extract of Psidium guajava (EEPG) by acute and subacute toxicity tests. Methods: Organization for Economic Co-operation and Development (OECD) 425 recommendations were used for the acute toxicity investigation in mice, while OECD 407 guidelines were used for the sub-acute toxicity study in mice. Mice were given oral doses of 2000 mg/kg/ body weight in the acute toxicity trial. They were then monitored individually for the first four hours, then for 24 hours, then at least once a day for 14 days. Ethanol extract of Psidium guajava (EEPG) was administered orally to male and female mice for 28 days at dosages of 250 mg/kg, 500 mg/kg, and 1000 mg/kg /body weight, respectively, in the subacute toxicity tests. Over the course of the experiment, general behavior, negative impacts, and mortality were noted. Hematological and biochemical markers, body weight, organ weight, and histopathological alterations were assessed. Results: in acute toxicity during the observation period, the mice examined showed no evidence of acute toxicity or mortality at the limit dosages of 2000 mg/kg/body weight. The findings of subacute toxicity testing revealed no anomalies associated with treatment in terms of biochemical, hematological and histopathology markers at the maximum dose of 1000 mg/kg /body weight. Conclusion: the substance showed a favorable safety profile, with no acute and subacute toxicity or mortality at 2000 mg/kg and no treatment-related adverse effects at 1000 mg/kg/body weight/day in mice.